Stock Screener App

Gratuito -

Installare

5.0955

1.71% 0.0855

after-market

Dopo l'orario di chiusura: 5.10 0.0045 +0.09%

Champions Oncology Inc (CSBR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Champions Oncology Inc Borsa (CSBR) Ultime notizie

Champions Oncology Q1 Results: Adj. EPS up 400% to $0.05 - scanx.trade

Champions Oncology (CSBR) Q1 Fiscal 2027 Earnings Call: Revenue Up 9%, Services Margin Reaches 51% - TradingKey

Champions Oncology Q1 Earnings Call Highlights - Yahoo Finance

Earnings call transcript: Champions Oncology tops Q1 2027 estimates, shares slip - Investing.com

Champions Oncology earnings beat by $0.06, revenue topped estimates - Investing.com

Champions Oncology reports Q1 revenue $15.2M, adjusted EBITDA $0.7M and oncology services margin 51% - TradingView

CSBR: Revenue up 8.8% to $15.2M, oncology margin at 51%, adjusted EBITDA $671K, net loss $426K - TradingView

Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2026 - marketscreener.com

Champions Oncology posts better-than-expected Q1, but shares edge lower on higher costs - Investing.com

CHAMPIONS ONCOLOGY ($CSBR) Releases Q1 2027 Earnings - quiverquant.com

Champions Oncology Reports Revenue of $15.2 Million - Weatherford Democrat

Oracle, Adobe, Copart and more set to report earnings Thursday By Investing.com - Investing.com Australia

Oracle, Adobe, Copart and more set to report earnings Thursday - Investing.com

CSBR Q1'26 Earnings: EPS estimate is (0.01) USD - TradingView

Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026 - Black Hills Pioneer

A cancer research company will report results Sept. 10 - Stock Titan

CSBR - Finviz

Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging - New Castle News

New imaging follows cancer treatments inside tumors—and links uptake to response - Stock Titan

Anixa Biosciences Inc. (ANIX) Peer Comparison – Compare with Others - Value Research

Champions (CSBR) Range: Finishes 4.86% Up at $5.18 in the Latest Session; Price Setup: the Near-Term Reference Band Stretches From $4.92 to $5.44 in the Available RecordHidden Order - vinanet.vn

North-America Humanized Mouse and Rat Model Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets

Japan Humanized Mouse and Rat Model Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets

Rest-Of-Asia-Pacific Humanized Mouse and Rat Model Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets

Latin-America Humanized Mouse and Rat Model Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets

Comedian Michael Kosta Headlines Karmanos Comedy Champions on New October Date, Hosted by 101 WRIF's Jade Springart - PR Newswire

Precision Trading with Champions Oncology Inc. (CSBR) Risk Zones - Stock Traders Daily

OSTX Stock Price and Chart — AMEX:OSTX - TradingView

Manulife China Bank Life Champions Early Health Action and Financial Planning at The Art of Longevity - Mindanao Times

Residential Social Vulnerability Associated With Worse Survival Among Black Women With Epithelial Ovarian Cancer - The ASCO Post

China Patient Derived Xenografts/PDX Models Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets

KLRS Stock Price and Chart — NASDAQ:KLRS - TradingView

NMAD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Oil Prices Rise as Iran Draft Plan Proposes Barring U.S. and Israel From Strait of HormuzAnnual Report - Vinanet

Technical Reactions to CSBR Trends in Macro Strategies - Stock Traders Daily

Champions Oncology Inc (CSBR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Champions Oncology (NASDAQ:CSBR) Stock Price Crosses Below 200 Day Moving AverageHere's Why - MarketBeat

Champions Oncology (CSBR) Pulls Back 2.7% as Shares Test Support Near $5.33Sweep Order Flow - vinanet.vn

Champions Oncology, Inc. Revenue Breakdown – NASDAQ:CSBR - TradingView

CSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI Push - theglobeandmail.com

Champions Oncology Inc (CSBR) (Q4 2026) Earnings Call Highlights: Record Revenue and Positive ... By GuruFocus - Investing.com Canada

AgomAb Therapeutics (AGMB) Holds Steady Near Resistance as Biotech Sector Shows Mixed SentimentHead and Shoulders - vinanet.vn

Champions Oncology Inc (CSBR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Champions Oncology Inc (CSBR) Institutional Confidence - TradingKey

Earnings call transcript: Champions Oncology posts record Q4 2026 revenue By Investing.com - Investing.com Nigeria

Champions Oncology Inc (CSBR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Champions Oncology Q4 Earnings Call Highlights - Yahoo Finance

Earnings call transcript: Champions Oncology posts record Q4 2026 revenue - Investing.com

CSBR: Record revenue and positive Adjusted EBITDA achieved, with strong core services growth and margin gains - TradingView

CHAMPIONS ONCOLOGY, INC. FY 2026: Revenue $59.43M, EPS ($0.08) — 10-K Summary - TradingView

CSBR: Revenue up 4.4% to $59.4M, but net loss of $1.2M driven by higher R&D and operating costs - TradingView

Rising costs push Champions Oncology (NASDAQ: CSBR) into 2026 loss - Stock Titan

Champions Oncology, Inc. Reports Earnings Results for the Full Year Ended April 30, 2026 - marketscreener.com

Champions Oncology reports record $59.4M revenue, positive adjusted EBITDA for FY2026 - TradingView

CSBR: Record revenue and positive adjusted EBITDA achieved, driven by core research services growth - TradingView

CHAMPIONS ONCOLOGY ($CSBR) Releases Q4 2026 Earnings - Quiver Quantitative

Champions Oncology Q4 revenue rises; margin improves driven by cost discipline - TradingView

Champions Oncology Reports Record Annual Revenue of $59 Million - ACCESS Newswire

BRIEF-Champions Oncology Q4 Adjusted EPS USD 0.01 - TradingView

At fiscal year-end, Champions Oncology had $4.9M cash, no debt - Stock Titan

Champions Oncology Inc (CSBR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Champions Oncology Inc (CSBR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Champions Oncology Inc (CSBR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

CSBR|Champions Oncology Inc|Price:6.160|Chg%:+0.030 - TradingKey

Champions Oncology, Inc. Revenue Breakdown – MUN:2I3 - TradingView

Enterprise value to EBITDA forward of Champions Oncology, Inc. – MUN:2I3 - TradingView

Champions Oncology, Inc. Revenue Breakdown – FWB:2I3 - TradingView

CSBR Q4'25 Earnings: EPS estimate is (0.05) USD - TradingView

CSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside? - TradingView

RPRX

$58.75

3.04%

INSM

$127.28

1.18%

ROIV

$40.94

2.08%

ALNY

$247.51

4.07%

ONC

$341.80

2.62%

RVMD

$203.35

2.08%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters